LABOPHARM COMPLETES PUBLIC OFFERING FOR ESTIMATED NET PROCEEDS OF US$93.3 MILLION

A A

Labopharm Inc. today announced the completion of its previously announced public offering of 12,650,000 common shares, which includes exercise in full of the underwriters' over-allotment option. The common shares were sold at a price of US$8.00 per share for total estimated net proceeds to the Company of US$93.3 million (CDN$104.8 million)(1), after deducting underwriting discounts and commissions and estimated offering expenses.
PR Newswire